$383 Million is the total value of Pennant Investors, LP's 46 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 24.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MU | Buy | MICRON TECHNOLOGY INC | $56,689,430 | +57.1% | 431,000 | +40.8% | 14.82% | +65.8% |
| AMZN | Sell | AMAZON COM INC | $46,380,000 | -13.1% | 240,000 | -18.9% | 12.12% | -8.3% |
| TDG | Sell | TRANSDIGM GROUP INC | $41,357,513 | -20.0% | 32,371 | -22.9% | 10.81% | -15.6% |
| SATS | ECHOSTAR CORPcl a | $38,348,652 | +25.0% | 2,153,209 | 0.0% | 10.02% | +31.9% | |
| MSFT | Sell | MICROSOFT CORP | $35,756,000 | -24.1% | 80,000 | -28.6% | 9.35% | -19.9% |
| GOOGL | Sell | ALPHABET INCcap stk cl a | $33,333,450 | +11.0% | 183,000 | -8.0% | 8.71% | +17.1% |
| AR | Sell | ANTERO RESOURCES CORP | $27,278,680 | -17.0% | 836,000 | -26.2% | 7.13% | -12.4% |
| PERIMETER SOLUTIONS SA | $18,009,000 | +5.5% | 2,300,000 | 0.0% | 4.71% | +11.3% | ||
| AR | ANTERO RESOURCES CORPcall | $16,315,000 | +12.5% | 500,000 | 0.0% | 4.26% | +18.7% | |
| ODP | THE ODP CORP | $15,708,000 | -26.0% | 400,000 | 0.0% | 4.11% | -21.9% | |
| VMI | New | VALMONT INDS INC | $10,978,000 | – | 40,000 | +100.0% | 2.87% | – |
| New | GE VERNOVA INC | $10,290,600 | – | 60,000 | +100.0% | 2.69% | – | |
| VRT | New | VERTIV HOLDINGS CO | $9,955,550 | – | 115,000 | +100.0% | 2.60% | – |
| New | IRIS ENERGY LTDordinary shares | $5,306,300 | – | 470,000 | +100.0% | 1.39% | – | |
| New | CORE SCIENTIFIC INC NEW | $4,650,000 | – | 500,000 | +100.0% | 1.22% | – | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1,589,370 | -6.2% | 170,900 | 0.0% | 0.42% | -1.2% | |
| NRIX | NURIX THERAPEUTICS INC | $1,185,416 | +42.0% | 56,800 | 0.0% | 0.31% | +49.8% | |
| NVAX | NOVAVAX INC | $763,398 | +164.9% | 60,300 | 0.0% | 0.20% | +181.7% | |
| ALT | ALTIMMUNE INC | $730,170 | -34.7% | 109,800 | 0.0% | 0.19% | -31.0% | |
| FGEN | FIBROGEN INC | $685,643 | -62.0% | 768,400 | 0.0% | 0.18% | -60.0% | |
| AGIO | AGIOS PHARMACEUTICALS INC | $651,112 | +47.5% | 15,100 | 0.0% | 0.17% | +56.0% | |
| FATE | FATE THERAPEUTICS INC | $479,208 | -55.3% | 146,100 | 0.0% | 0.12% | -53.0% | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $458,676 | – | 55,800 | +100.0% | 0.12% | – |
| ENTA | ENANTA PHARMACEUTICALS INC | $455,247 | -25.7% | 35,100 | 0.0% | 0.12% | -21.7% | |
| IGMS | IGM BIOSCIENCES INC | $445,863 | -28.8% | 64,900 | 0.0% | 0.12% | -24.5% | |
| ERASCA INC | $392,232 | +14.6% | 166,200 | 0.0% | 0.10% | +21.2% | ||
| RCUS | ARCUS BIOSCIENCES INC | $360,951 | -19.3% | 23,700 | 0.0% | 0.09% | -15.3% | |
| ETNB | 89BIO INC | $356,445 | -31.2% | 44,500 | 0.0% | 0.09% | -27.3% | |
| ZYMEWORKS INC | $329,337 | -19.1% | 38,700 | 0.0% | 0.09% | -14.9% | ||
| ARCT | ARCTURUS THERAPEUTICS HLDGS | $318,985 | -27.9% | 13,100 | 0.0% | 0.08% | -24.5% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $299,172 | -47.9% | 128,400 | 0.0% | 0.08% | -45.1% | |
| CHRS | COHERUS BIOSCIENCES INC | $290,813 | -27.6% | 168,100 | 0.0% | 0.08% | -24.0% | |
| RLAY | RELAY THERAPEUTICS INC | $276,448 | -21.4% | 42,400 | 0.0% | 0.07% | -17.2% | |
| REPL | REPLIMUNE GROUP INC | $274,500 | +10.2% | 30,500 | 0.0% | 0.07% | +16.1% | |
| QURE | UNIQURE NV | $217,280 | -13.8% | 48,500 | 0.0% | 0.06% | -8.1% | |
| MCRB | SERES THERAPEUTICS INC | $211,567 | -6.5% | 292,300 | 0.0% | 0.06% | -1.8% | |
| CMPX | COMPASS THERAPEUTICS INC | $199,000 | -49.5% | 199,000 | 0.0% | 0.05% | -46.9% | |
| SAGE | SAGE THERAPEUTICS INC | $190,050 | -42.0% | 17,500 | 0.0% | 0.05% | -38.3% | |
| GETAROUND INC | $188,741 | -54.4% | 1,348,153 | 0.0% | 0.05% | -52.4% | ||
| MGNX | MACROGENICS INC | $186,150 | -71.1% | 43,800 | 0.0% | 0.05% | -69.4% | |
| ALLK | ALLAKOS INC | $186,100 | -20.6% | 186,100 | 0.0% | 0.05% | -15.5% | |
| ALVR | ALLOVIR INC | $156,016 | -4.2% | 215,700 | 0.0% | 0.04% | +2.5% | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $132,516 | -74.0% | 32,400 | 0.0% | 0.04% | -72.2% | |
| BTAI | BIOXCEL THERAPEUTICS INC | $107,392 | -54.6% | 83,900 | 0.0% | 0.03% | -52.5% | |
| BLUE | BLUEBIRD BIO INC | $86,019 | -23.1% | 87,400 | 0.0% | 0.02% | -21.4% | |
| GRAB HOLDINGS LIMITED*w exp 99/99/999 | $12,888 | -20.5% | 80,000 | 0.0% | 0.00% | -25.0% | ||
| Exit | AIRSPAN NETWORKS HOLDINGS IN | $0 | – | -1,047,473 | -100.0% | -0.03% | – | |
| AGEN | Exit | AGENUS INC | $0 | – | -469,600 | -100.0% | -0.07% | – |
| Exit | TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $0 | – | -55,800 | -100.0% | -0.11% | – | |
| Exit | ENOVIS CORPORATION | $0 | – | -400,000 | -100.0% | -6.19% | – | |
| AAPL | Exit | APPLE INCput | $0 | – | -160,000 | -100.0% | -6.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC | 24 | Q2 2024 | 16.4% |
| TRANSDIGM GROUP INC | 24 | Q2 2024 | 13.2% |
| ANTERO RESOURCES CORP | 24 | Q2 2024 | 11.9% |
| ALPHABET INC | 23 | Q2 2024 | 23.5% |
| MICRON TECHNOLOGY INC | 21 | Q2 2024 | 19.8% |
| MICROSOFT CORP | 18 | Q2 2024 | 16.1% |
| ANTERO MIDSTREAM CORP | 18 | Q2 2023 | 8.7% |
| DISH NETWORK CORPORATION | 17 | Q3 2023 | 21.1% |
| CHARTER COMMUNICATIONS INC N | 13 | Q3 2021 | 14.4% |
| PERIMETER SOLUTIONS SA | 11 | Q2 2024 | 4.7% |
View Pennant Investors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Pennant Investors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.